$428.26
-0.17-0.04%
Last update: Oct 16, 4:01 PM
$426.44
-1.99-0.46%
Elevance Health Inc
ELVNYSE
Elevance Health (ELV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Elevance Health (ELV) last issued guidance on September 10, 2026 for fiscal year 2026. The company guided revenue in the range of for the period.
Compared to prior guidance, Elevance Health maintained its EPS outlook from a previous range of $30 - $30.
Elevance Health has issued 12 guidance updates between January 25, 2023 and November 10, 2025. During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.20 | $10.74 | $3.10 | $4.96 |
| Actual | $7.45 | $12.58 | $3.33 | $6.03 |
| Surprise | +20.2% | +17.1% | +7.42% | +21.6% |
| Revenue | ||||
| Estimate | $48.59B | $47.98B | $49.47B | $49.51B |
| Actual | $49.83B | $49.49B | $49.31B | $50.09B |
| Surprise | +2.54% | +3.15% | -0.32% | +1.17% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $4.69 | $2.45 | $11.88 | $7.79 |
| Revenue | ||||
| Consensus | $49.05B | $48.05B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $7.45 | $6.20 | 20.2 % |
| Q1 | Apr 22, 2026 | $12.58 | $10.74 | 17.1 % |
| Q4 | Jan 28, 2026 | $3.33 | $3.10 | 7.42 % |
| Q3 | Oct 21, 2025 | $6.03 | $4.96 | 21.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 15, 2026 | $49.83B | $48.59B | 2.54 % |
| Q1 | Apr 22, 2026 | $49.49B | $47.98B | 3.15 % |
| Q4 | Jan 28, 2026 | $49.31B | $49.47B | -0.32 % |
| Q3 | Oct 21, 2025 | $50.09B | $49.51B | 1.17 % |
